Salivary biomarkers: toward future clinical and diagnostic utilities

JM Yoshizawa, CA Schafer, JJ Schafer… - Clinical microbiology …, 2013 - Am Soc Microbiol
The pursuit of timely, cost-effective, accurate, and noninvasive diagnostic methodologies is
an endeavor of urgency among clinicians and scientists alike. Detecting pathologies at their …

Saliva proteome research: current status and future outlook

BL Schulz, J Cooper-White… - Critical reviews in …, 2013 - Taylor & Francis
Human saliva harbours proteins of clinical relevance and about 30% of blood proteins are
also present in saliva. This highlights that saliva can be used for clinical applications just as …

Salivary microRNAs and oral cancer detection

JM Yoshizawa, DTW Wong - MicroRNA Protocols, 2013 - Springer
MicroRNAs (miRNAs) in human saliva have recently become an emerging field in saliva
research for diagnostics applications and its potential role in biological implications. miRNAs …

Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma

SR Punyani, RS Sathawane - Clinical oral investigations, 2013 - Springer
Abstract Background Interleukin 8 (IL-8) is a pro-angiogenic, pro-inflammatory mediator that
belongs to the family of chemokines. Due to its pro-angiogenic characteristic, it may play a …

[PDF][PDF] Short Communication Salivary Levels of TNF-α and IL-6 in Patients with Oral Premalignant and Malignant Lesions

M Jureti, R Cerovi, M Belušić-Gobi, IB Pršo… - Folia Biologica …, 2013 - academia.edu
The aim of this study was to determine the salivary concentrations of tumour necrosis factor
α (TNF-α) and interleukin 6 (IL-6) in patients with premalignant and malignant lesions. The …

Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer

G Prasad, M McCullough - International journal of dentistry, 2013 - Wiley Online Library
Chemokines have been shown to be important in both inflammation and carcinogenesis and
are able to be measured in saliva with relatively robust methods including enzyme‐linked …

Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer

PY Chang, YB Kuo, TL Wu, CT Liao, YC Sun… - Clinical Chemistry and …, 2013 - degruyter.com
Background: Oral cavity cancer ranks as the fourth leading cancer in men in Taiwan. The
development of a serum biomarker panel for early detection and disease monitoring is …

Pretreatment interleukin-6 serum levels are associated with patient survival for oral cavity squamous cell carcinoma

KP Chang, HK Kao, CC Wu, KH Fang… - … --Head and Neck …, 2013 - journals.sagepub.com
Objective This study aims to determine the role of serum interleukin-6 concentration for oral
cavity squamous cell carcinomas. Study Design Cohort study. Setting Tertiary referral center …

Systems and methods for intra-oral drug delivery

C Li, WC Carlyle, P De Smedt, A Abolfathi… - US Patent …, 2013 - Google Patents
(73) Assignee: Align Technology, Inc., San Jose, CA 3,660,900 A 5, 1972 Andrews (US)
3,665,770 A 5/1972 Sagi et al. 3,683,502 A 8, 1972 Wallshein (*) Notice: Subject to any …

Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma

T Kamatani, S Shiogama, Y Yoshihama, S Kondo… - Cytokine, 2013 - Elsevier
The objective of this study was to evaluate cytokines in unstimulated whole saliva (UWS) of
oral squamous cell carcinoma (OSCC) patients as compared to those with pre-and post …